Value propositions in future pharmaceutical benefits.
Within this decade, benefit managers will see radically new diagnostics and drugs that will call for changes in drug benefit planning. This article provides insight into various value propositions that must be taken into account in a drug benefit plan, along with considerations integral to those propositions; some key trends; and the new drug pipeline. Benefit managers must remain aware of the drug pipeline and benefit trends and utilize the insight of peers or other experts in strategic benefit planning.